11/20
07:56 am
lucd
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
Medium
Report
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
11/18
08:15 am
lucd
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Medium
Report
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/15
10:27 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its price target lowered by analysts at Cantor Fitzgerald from $3.00 to $2.00. They now have an "overweight" rating on the stock.
Low
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its price target lowered by analysts at Cantor Fitzgerald from $3.00 to $2.00. They now have an "overweight" rating on the stock.
11/14
11:13 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $3.00 price target on the stock.
Low
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $3.00 price target on the stock.
11/14
08:15 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
Medium
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
11/14
02:31 am
lucd
Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ... [Yahoo! Finance]
Medium
Report
Lucid Diagnostics Inc (LUCD) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amid ... [Yahoo! Finance]
11/13
11:29 am
lucd
Lucid Diagnostics Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Lucid Diagnostics Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
11/13
11:03 am
lucd
Lucid Diagnostics reports Q3 results [Seeking Alpha]
Low
Report
Lucid Diagnostics reports Q3 results [Seeking Alpha]
11/13
08:01 am
lucd
Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
Medium
Report
Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results
11/7
08:01 am
lucd
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
Medium
Report
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
11/5
08:04 am
lucd
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers [Yahoo! Finance]
Medium
Report
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers [Yahoo! Finance]
11/5
08:01 am
lucd
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers
Medium
Report
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers
10/30
08:31 am
lucd
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
Neutral
Report
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
10/15
09:11 am
lucd
Lucid Diagnostics gets notice of allowance for patent underlying its esoguard esophageal DNA test [Seeking Alpha]
Low
Report
Lucid Diagnostics gets notice of allowance for patent underlying its esoguard esophageal DNA test [Seeking Alpha]
10/15
07:51 am
lucd
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test
Low
Report
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test
10/9
08:01 am
lucd
Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit
10/8
07:49 am
lucd
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
Medium
Report
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
10/1
08:01 am
lucd
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
Low
Report
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
9/24
08:01 am
lucd
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test
Low
Report
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test
9/10
08:01 am
lucd
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its price target lowered by analysts at Ascendiant Capital Markets from $7.50 to $7.25. They now have a "buy" rating on the stock.
Low
Report
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its price target lowered by analysts at Ascendiant Capital Markets from $7.50 to $7.25. They now have a "buy" rating on the stock.
9/10
08:01 am
lucd
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress [Yahoo! Finance]
Low
Report
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress [Yahoo! Finance]
9/10
07:56 am
lucd
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
Low
Report
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
9/3
07:53 am
lucd
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health [Yahoo! Finance]
Low
Report
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health [Yahoo! Finance]
9/3
07:51 am
lucd
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
Neutral
Report
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health